These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 11231428

  • 1. Prognostic implications of left ventricular hypertrophy.
    Vakili BA, Okin PM, Devereux RB.
    Am Heart J; 2001 Mar; 141(3):334-41. PubMed ID: 11231428
    [Abstract] [Full Text] [Related]

  • 2. Prevalence and determinants of electrocardiographic left ventricular hypertrophy among a multiethnic population of postmenopausal women (The Women's Health Initiative).
    Oberman A, Prineas RJ, Larson JC, LaCroix A, Lasser NL.
    Am J Cardiol; 2006 Feb 15; 97(4):512-9. PubMed ID: 16461048
    [Abstract] [Full Text] [Related]

  • 3. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension.
    Brown DW, Giles WH, Croft JB.
    Am Heart J; 2000 Dec 15; 140(6):848-56. PubMed ID: 11099987
    [Abstract] [Full Text] [Related]

  • 4. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Oct 15; 25(148):309-14. PubMed ID: 19145927
    [Abstract] [Full Text] [Related]

  • 5. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B, Losartan Intervention for Endpoint reduction in hypertension Study Investigations.
    Circulation; 2003 Aug 12; 108(6):684-90. PubMed ID: 12885747
    [Abstract] [Full Text] [Related]

  • 6. Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women.
    Westerhout CM, Lauer MS, James S, Fu Y, Wallentin L, Armstrong PW, GUSTO IV ACS Investigators.
    Eur Heart J; 2007 Sep 12; 28(17):2064-9. PubMed ID: 17600040
    [Abstract] [Full Text] [Related]

  • 7. [Prognostic implications of left ventricular hypertrophy in arterial hypertension].
    Kannel WB.
    Arch Mal Coeur Vaiss; 1990 Dec 12; 83 Spec No 4():11-21. PubMed ID: 2150470
    [Abstract] [Full Text] [Related]

  • 8. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
    Okin PM, Devereux RB, Gerdts E, Snapinn SM, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    Circulation; 2006 Mar 28; 113(12):1588-96. PubMed ID: 16534012
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of electrocardiographic criteria for left ventricular hypertrophy.
    Hsieh BP, Pham MX, Froelicher VF.
    Am Heart J; 2005 Jul 28; 150(1):161-7. PubMed ID: 16084164
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Usefulness of electrocardiographic and echocardiographic left ventricular hypertrophy to predict adverse events in patients with a first non-ST-elevation acute myocardial infarction.
    Barrabés JA, Figueras J, Cortadellas J, Lidón RM, Ibars S.
    Am J Cardiol; 2009 Feb 15; 103(4):455-60. PubMed ID: 19195501
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: the HEART Survey study.
    Verdecchia P, Reboldi G, Angeli F, Avanzini F, de Simone G, Pede S, Perticone F, Schillaci G, Vanuzzo D, Maggioni AP, HEART Survey Study Group.
    Am J Hypertens; 2007 Sep 15; 20(9):997-1004. PubMed ID: 17765142
    [Abstract] [Full Text] [Related]

  • 13. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR, Cea-Calvo L, Bertomeu V, Aznar J, for Investigators study VIIDA.
    Rev Esp Cardiol; 2007 Feb 15; 60(2):148-56. PubMed ID: 17338880
    [Abstract] [Full Text] [Related]

  • 14. Relation of electrocardiographic left ventricular hypertrophy to blood pressure, body mass index, serum lipids and blood sugar levels in adult Nigerians.
    Opadijo OG, Omotoso AB, Akande AA.
    Afr J Med Med Sci; 2003 Dec 15; 32(4):395-9. PubMed ID: 15259925
    [Abstract] [Full Text] [Related]

  • 15. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.
    Verdecchia P, Angeli F, Pittavini L, Gattobigio R, Benemio G, Porcellati C.
    Ital Heart J; 2004 Jul 15; 5(7):505-10. PubMed ID: 15487267
    [Abstract] [Full Text] [Related]

  • 16. Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients.
    Verdecchia P, Sleight P, Avanzini F, de Simone G, Pede S, Perticone F, Schillaci G, Vanuzzo D, Angeli F, Reboldi GP, Maggioni AP.
    Ital Heart J; 2003 Jul 15; 4(7):479-83. PubMed ID: 14558300
    [Abstract] [Full Text] [Related]

  • 17. The prevalence of left ventricular hypertrophy and associated factors in a Thai population.
    Sriratanasathavorn C, Bhuripanyo K, Mahanonda N, Leowattana W, Ruangratanaamporn O, Chotinaiwattarakul C, Krittayapong R, Kangkagate C, Chaitiraphan S.
    J Med Assoc Thai; 2000 Nov 15; 83 Suppl 2():S218-22. PubMed ID: 11194018
    [Abstract] [Full Text] [Related]

  • 18. Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy.
    Smilde TD, Asselbergs FW, Hillege HL, Voors AA, Kors JA, Gansevoort RT, van Gilst WH, de Jong PE, Van Veldhuisen DJ.
    Am J Hypertens; 2005 Mar 15; 18(3):342-7. PubMed ID: 15797651
    [Abstract] [Full Text] [Related]

  • 19. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E, Muiesan ML.
    J Hypertens Suppl; 2002 May 15; 20(2):S34-8. PubMed ID: 12183849
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, Edelman JM, Dahlöf B, Devereux RB, LIFE Study Investigators.
    Circulation; 2009 Apr 14; 119(14):1883-91. PubMed ID: 19332468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.